AstraZeneca demands £19m in continued wrangle over Bristol site

AstraZeneca is claiming £19m in damages after the collapse of its former pharmaceuticals site near Bristol under a contract manufacturing company. David Rubin & Partners was appointed administrator of the Avlon site in February 2019, about two years after AstraZeneca